Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

resTORbio
501 Boylston Street, Suite 6102
Boston, MA 02116
Phone: 617-482-2333
https://www.restorbio.com/

resTORbio is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio's lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caused by immunosenescence, the decline in immune function that occurs during aging.

Key Contact
Name
Chen Schor
Title
President and CEO
Funding Events

Date
Amount
Type
Investors
Valuation
11/30/17 $40,000,000 Series B Fidelity Management & Research Company
Nest.Bio Ventures
OrbiMed Advisors
Quan Capital
Rock Springs Capital
undisclosed